摘要
目的比较经尿道前列腺电切术(TURP)与经尿道双极等离子前列腺腔内剜除术(TPKEP)治疗前列腺增生患者的临床效果,并分析其对患者性功能的影响。方法选取我院2016年1月至2018年1月86例前列腺增生患者为研究对象,将实施经尿道双极等离子前列腺腔内剜除术的作为观察对象(TPKEP组,n=44),将行经尿道前列腺电切术的患者作为对照组(TURP组,n=42),收集两组患者的围手术数据和术后性功能状况资料并进行比较。结果TPKEP组患者手术时间65.4±15.8 min、术中出血量231.3±77.5 mL及导管留置时间5.5±0.6 d,TURP组患者手术时间76.8±16.9 min、术中出血量346.2±81.4 mL及导管留置时间6.0±0.7 d,两组间的差异有统计学意义(P<0.05)。TPKEP组患者术后勃起功能障碍、逆行射精发生率低于TURP组患者(P<0.05);两组患者术后射精痛和性欲下降的差异无统计学意义(P>0.05)。结论与TURP相比,TPKEP术中出血量较少,术后对BPH患者性功能的影响较小。
Objective To investigate the sexual function and clinical changes of transurethral electroresection of the prostate and transurethral plasmakinetic enucleation of the prostate on patients with prostatic hyperplasia.Methods 86 patients with prostatic hyperplasia from January 2016 to January 2018 were selected and divided into two groups.The 42 patients in control group received transurethral electroresection and the 44 patients in the observation group received transurethral plasmakinetic enucleation of the prostate.The sexual function and clinical changes in related indicators was observed after treatment.Results In the observation group,operation time was 65.4±15.8 min,intraoperative blood loss was 231.3±77.5 ml and catheter indwelling time was 5.5±0.6 d.In control group,operation time was 76.8±16.9 min,intraoperative blood loss was 346.2±81.4 ml and catheter indwelling time(6.0±0.7)d,the observation group was better than the control group,the difference is statistically significant(P<0.05).In observation of the group,the ED rate and the retrograde ejaculation rate were lower,the difference between the two groups has statistical significance(P<0.05).Conclusion Compare with TURP,TPKEP has less intraoperative blood loss and no negative influence on the quality of sexual function.
作者
冯传顺
刘云飞
彭乃雄
邓灵
王细生
FENG Chuan-shun;LIU Yun-fei;PENG Nai-xiong;DENG Ling;WANG Xi-sheng(Department of Urology,Longhua district Central Hospital of Shenzhen,Shenzhen 518110,China)
出处
《岭南现代临床外科》
2020年第4期472-475,共4页
Lingnan Modern Clinics in Surgery
关键词
前列腺增生
性功能
治疗
prostatic hyperplasia
sexual function
treatment